Are you Dr. Chamberlain?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 71 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Seattle Cancer Care Alliance
825 Eastlake Ave E Ms G-6800 Pob 19023
Seattle, WA 98109Phone+1 813-362-4370
Summary
- Dr. Marc Chamberlain, MD is a neurologist in Seattle, Washington. He is currently licensed to practice medicine in Washington. He is affiliated with UW Medicine/University of Washington Medical Center and Seattle Children's Hospital.
Education & Training
University of California (San Francisco)Residency, Neurological Surgery, 1985 - 1986
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Child Neurology, 1982 - 1985
Los Angeles County-Harbor-UCLA Medical CenterResidency, Pediatrics, 1979 - 1980
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 1977 - 1979
Columbia University Vagelos College of Physicians and SurgeonsClass of 1977
Certifications & Licensure
WA State Medical License 2007 - 2017
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma Start of enrollment: 2006 Jul 01
- A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma Start of enrollment: 2008 Aug 01
- Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma Start of enrollment: 2008 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 38 citationsPhase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy.Patrick Y Wen, Jan Drappatz, John de Groot, Michael D Prados, David A Reardon
Neuro-Oncology. 2018-01-22 - 135 citationsTemozolomide: therapeutic limitations in the treatment of adult high-grade gliomas.Marc C. Chamberlain
Expert Review of Neurotherapeutics. 2010-10-01 - 20 citationsControversies in the Treatment of Elderly Patients With Newly Diagnosed GlioblastomaMatthias Holdhoff, Marc C. Chamberlain
Journal of the National Comprehensive Cancer Network. 2013-09-01
Press Mentions
Lantern Pharma Reports First Quarter 2024 Financial Results and Business HighlightsMay 14th, 2024
Professional Memberships
- Member
